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Purpose: A single systemic administration of N-methyl-N-nitrosourea (MNU) causes retinal degeneration involving
photoreceptor cell loss within 7 days. MNU-induced photoreceptor cell loss is due to apoptosis and is a reliable animal
model for human retinitis pigmentosa. The purpose of this study was to determine if p53 contributes to the development
of MNU-induced retinal degeneration in mice.
Methods: Eight-week-old p53−/−, p53+/−, and p53+/+ mice received an intraperitoneal injection of 60 mg/kg bodyweight
of MNU. Age-matched p53+/+ mice received the vehicle only (physiologic saline containing 0.05% acetic acid). Mice
were sacrificed and necropsied 7 days after the treatment. Both eyes were examined histologically and morphometrically
to determine retinal thickness, photoreceptor cell ratio, and retinal damage ratio.
Results: No mice died during the experiment, but the p53 null mice treated with MNU had a statistically significant weight
loss compared to the other groups. Histologically, all MNU-treated mice, regardless of p53 gene status, experienced retinal
degeneration characterized by photoreceptor cell loss (the disappearance of the outer nuclear layer and photoreceptor
layer) in both the central and peripheral retina. All MNU-treated mice had significantly decreased retinal thickness and
photoreceptor cell ratios at the central and peripheral retina and an increased retinal damage ratio compared to the vehicle-
treated control. The retinal changes caused by MNU in p53+/+, p53+/−, and p53−/− mice were not significantly different
and hence were related to a p53-independent apoptotic mechanism.
Conclusions: Because the absence of p53 did not prevent photoreceptor cell loss, we conclude that p53 is not essential
for MNU-mediated photoreceptor cell degeneration.
Retinitis  pigmentosa  (RP)  is  characterized  by  early
nyctalopia  and  noninflammatory,  bilateral,  progressive,
degenerative pigmentary retinopathy; the photoreceptor loss
is followed by perivascular pigment deposition within the
retina [1,2]. RP is a heterogeneous group of inherited retinal
disorders, and more than 160 different mutations of genes
encoding  proteins  with  remarkably  diverse  functions  are
known to cause photoreceptor degeneration (RetNet). Animal
models  of  retinal  degeneration  are  used  to  elucidate  the
mechanism of human RP [3,4] and to search for a treatment
or a cure [2,5]. Mutant mice used as models for RP [6] include
mice carrying the rodless retina or retinal degeneration (rd)
gene or the retinal degeneration slow (rds) gene; these mice
experience photoreceptor cell death caused by apoptosis [7,
8]. In addition to inherited RP models, there are chemically
induced retinal degeneration models. Mammalian eyes are
highly  sensitive  to  toxic  substances,  and  N-methyl-N-
nitrosourea  (MNU),  an  alkylating  agent  that  targets
photoreceptor  cells,  rapidly  induces  retinal  damage  via
apoptosis in animal species, including the mouse [5,9]. Within
7 days after MNU exposure, active signs of photoreceptor
degeneration are indistinct due to photoreceptor cell loss, and
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the inner nuclear layer is either in direct contact with the
choroid or is separated from it by a few layers of cells [10].
p53 is a transcription factor that regulates the activity of
genes  involved  in  cell-cycle  arrest,  apoptosis,  anti-
angiogenesis,  differentiation,  DNA  repair,  and  genomic
stability [11,12]. p53 mediates apoptosis in response to DNA
damage and cell-cycle perturbations; however, various forms
of p53-independent apoptosis have also been identified [13,
14]. Apoptosis occurs widely during the development of nerve
systems  [15,16],  including  the  visual  system  [17].
Developmental apoptosis in the nervous system is generally
p53  independent  since  most  p53-deficient  mice  develop
normally [13,18]. However, retinal ganglion cells provide a
convenient  model  system  to  investigate  p53-dependent
apoptosis during development [17].
Our goal in the present study is to elucidate the effect of
p53 on MNU-induced photoreceptor degeneration in mice.
We also discuss the involvement of p53 in different types of
retinal cells and on photoreceptor cell loss caused by different
stimuli.
METHODS
Animals: Female B6;129-Trp53tm1Brd N4 (p53−/−), N5 (p53+/
−), and N5 (p53+/+) mice were purchased at 5 to 8 weeks of
age  from  Taconic  (Germantown,  NY).  p53  knockout  and
wild-type mice were generated in 129/Sv-derived embryonic
stem  cells  (AB1)  and  were  backcrossed  onto  a  C57BL
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2919background  [19].  In  brief,  resultant  chimeras  were
backcrossed to C57BL/6J for two generations (N2). Then, the
mice were backcrossed to N3 for caesarean derivation and
backcrossed  to  N4  immediately  after  derivation.  The
homozygous colony was maintained at N4 through the mating
of  heterozygous  females  with  homozygous  males.  The
heterozygous  colony  was  maintained  at  N5  through  the
mating of N4 male homozygotes to C57BL/6NTac females.
The wild-type control colony was maintained at N5 through
the mating of N4 wild-type mice to C57BL/6NTac mice.
There  have  been  no  reports  of  spontaneous  retinal
degeneration in these knockout and wild-type mouse colonies.
Each  animal’s  genotype  was  determined  by  the  supplier
before shipment. Mice were maintained in specific pathogen-
free conditions and had free access to a commercial mix-feed
diet (CMF, 30 kGy; Oriental Yeast, Chiba, Japan) and water.
Animals were housed in plastic cages with paper-chip bedding
(Paper Clean; SLC, Hamamatsu, Japan) in an air-conditioned
room at 22±2 °C and 60%±10% relative humidity with a 12
h:12 h light–dark cycle. All cages were placed in the same
row, and the illumination intensity in the cages was less than
60 lux. All procedures were in accordance with the guidelines
for animal experimentation at Kansai Medical University,
Moriguchi, Japan.
Chemical and dose formulation: MNU (Sigma; St. Louis,
MO) was kept at −80 °C in the dark. The MNU solution was
dissolved in physiologic saline containing 0.05% acetic acid
just  before  use.  Mice  received  one  intraperitoneal  (i.p.)
injection of MNU at a dose of 60 mg/kg or an injection of
Figure 1. Percent bodyweight change of initial bodyweight in N-
methyl-N-nitrosourea (MNU) -treated p53−/−, p53+/−, and p53+/+
mice  and  vehicle-treated  p53+/+  control  mice  7  days  after  the
treatment. The MNU-treated p53 null mice experienced a significant
decrease in bodyweight as compared to vehicle-treated and MNU-
treated p53+/− and p53+/+ mice. Asterisk is p<0.01 and compared
with three other organs.
vehicle only (physiologic saline containing 0.05% acetic acid)
[10].
Experimental procedures: At 8 weeks of age, three p53−/−,
seven p53+/−, and seven p53+/+ mice received an i.p. injection
of  MNU  (60  mg/kg  bodyweight),  and  seven  p53+/+  mice
received an i.p. injection of vehicle. All mice were observed
daily for clinical signs of toxicity and were weighed at the time
of MNU injection and on the day of sacrifice. All mice were
inhalated  with  isoflurane  (Forane;  Abbot  Japan,  Tokyo,
Japan) and sacrificed 7 days after MNU or vehicle treatment.
At the time of sacrifice, both eyes were quickly removed and
complete necropsies were conducted on all animals.
Tissue fixation and processing: Eyes from each mouse were
fixed  overnight  in  methacarn  (60%  methanol,  30%
chloroform  and  10%  acetic  acid)  [20]  and  embedded  in
paraffin; then, 4-μm-thick sections were prepared and stained
with hematoxylin and eosin (H&E). Eye sections were cut
along a line parallel to the optic axis and nerve (including the
ora serrata). H&E sections of the retina were scanned to create
digital images with a high-resolution digital slide scanner
(NanoZoomer 2.0 Digital Pathology, Hamamatsu Photonics,
Hamamatsu,  Japan).  The  NanoZoomer-Digital-Pathology-
Annotations (ndpa)-image files were opened in color mode by
specific viewer software, NDP.view (Hamamatsu Photonics).
Morphometric analysis of retinal thickness, photoreceptor
cell ratio, and retinal damage ratio: As described previously
[20,21],  we  used  NDP.view  to  measure  the  total  retinal
thickness (from the internal limiting membrane to the pigment
epithelium), inner retinal thickness (from the internal limiting
membrane to the outer plexiform layer), and outer retinal
thickness  (from  the  outer  nuclear  layer  to  the  pigment
epithelial cell layer). The measurements were collected at the
central retina (approximately 400 μm from the optic nerve)
and the peripheral retina (approximately 400 μm from both
sides of the ciliary bodies). The photoreceptor cell ratio was
calculated  as  [(outer  retinal  thickness)/(total  retinal
thickness)]×100. To determine the area of retinal damage, the
entire length of the retina and the length of the damaged area
in H&E preparations were measured. A damaged retina was
designated  as  the  presence  of  less  than  four  rows  of
photoreceptor nuclei in the outer nuclear layer [20,21], and
the retinal damage ratio was calculated as [(length of damaged
retina/whole  retinal  length)]×100.  Two  toxicology
pathologists (K.Y. and A.T.) certified by the Japanese Society
of  Toxicologic  Pathology  performed  the  histopathological
and  morphometrical  evaluations,  according  to  previously
described  histopathological  terminology  and  diagnostic
criteria [20,21].
Statistical analysis: All discrete values, expressed as the mean
±standard error (SEM), were analyzed with the two-tailed
independent  Student  t-test  for  unpaired  samples  after
confirming  the  homogeneity  of  variances.  MNU-treated
retinas (regardless of p53 status) were compared with vehicle-
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2920treated  p53+/+  retinas,  and  the  MNU-treated  retinas  were
compared based on their p53 status. A p value <0.05 was
considered to show a statistically significant difference.
RESULTS
General remarks: All mice remained healthy during the 7-day
experimental period, and the MNU-treated p53+/− and p53+/+
MNU did not experience weight loss (Figure 1). However, the
MNU-treated p53−/− mice revealed a statistically significant
weight  loss;  their  bodyweight  7  days  after  treatment  was
70.3% of their initial weight (Figure 1). In the MNU-treated
p53−/− mice, a severe degree of atrophic changes was detected
in the lymph–hematopoietic system (thymus, spleen, lymph
node, and bone marrow).
Retinal change caused by N-methyl-N-nitrosourea: Retinal
histology was studied 7 days after MNU treatment. In vehicle-
treated p53+/+ mice, photoreceptor nuclei at the central retina
consisted of more than ten layers of cells, and the peripheral
retina consisted of more than seven layers of cells (Figure 2).
In contrast, regardless of p53 status, the outer nuclear layer of
MNU-treated mice contained no photoreceptor nuclei or only
a few layers of nuclei at both the central and peripheral retina
(Figure  2).  The  remaining  photoreceptor  nuclei  in  MNU-
treated  mice  were  densely  stained;  their  chromatin  was
clumped, and large basophilic bodies were present in between
the  remaining  photoreceptor  nuclei.  The  MNU-induced
changes were restricted to photoreceptor cells.
Morphometric analysis of retinal damage: Seven days after
MNU treatment, the total retinal thickness and outer retinal
thickness  of  all  mice,  regardless  of  p53  status,  was
significantly  decreased  in  both  the  central  and  peripheral
retina compared to the vehicle-treated p53+/+ mice. In the
MNU-treated mice, neither the total retinal thickness nor the
outer retinal thickness at the central and peripheral retina was
significantly  different  based  on  the  p53  status.  However,
MNU did not cause any changes in inner retinal thickness as
the  inner  retinal  thickness  in  MNU-treated  mice  was
comparable to that of vehicle-treated mice (data not shown).
To further evaluate the effects of p53 on retinal thickness, the
photoreceptor cell ratio was calculated (Figure 3). In vehicle-
treated p53+/+ mice, the outer retinal ratio at the central and
peripheral retina was 51±4% and 55±3%, respectively, while
in MNU-treated p53−/−, p53+/−, and p53+/+ retina, it decreased
to 22±8% and 26±5%, 27±4% and 25±6%, and 27±8% and
Figure 2. Retinal changes 7 days after a single systemic administration of 60 mg/kg N-methyl-N-nitrosourea (MNU) to p53−/−, p53+/−, and
p53+/+ mice. In MNU-treated p53−/−, p53+/−, and p53+/+ mice, the outer nuclear layer and photoreceptor layer disappeared in both the peripheral
and central retina. Equivalent levels of severe retinal degeneration were detected in MNU-treated p53−/−, p53+/−, and p53+/+ mice. GCL,
ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRL,
photoreceptor cell layer; and PEL, pigment epithelial cell layer. The sections were stained with hematoxylin and eosin. The scale bar represents
70 μm.
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292122±5%, respectively. Regardless of the p53 gene status, the
photoreceptor cell ratio in the central and peripheral retina was
not significantly different in the three groups of MNU-treated
mice.
To evaluate the degree of disease progression, the retinal
damage ratio was compared among the groups (Figure 4). In
MNU-treated  p53−/−,  p53+/−,  and  p53+/+  retina,  the  retinal
damage ratio was 98.5±2.1%, 85.0±10.2%, and 93.3±5.6%,
respectively. The MNU-induced damage reached almost the
entire retina, and the p53 gene status did not influence the
disease progression. As anticipated, the retinal damage ratio
in vehicle-treated p53+/+ mice was 0%.
Figure 3. Photoreceptor cell ratio in the central and peripheral retina
7 days after a single systemic administration of 60 mg/kg N-methyl-
N-nitrosourea  (MNU)  to  p53−/−,  p53+/−,  and  p53+/+  mice.
Photoreceptor cell ratio was calculated as [(outer retinal thickness)/
(total retinal thickness)]×100. In mice treated with MNU, regardless
of their p53 status, the total retinal thickness and the outer retinal
thickness  of  the  central  and  peripheral  retina  were  significantly
decreased,  resulting  in  a  statistically  significant  decrease  in  the
photoreceptor  ratio  of  MNU-treated  mice  compared  to  vehicle-
treated  controls.  Asterisk  is  p<0.01  and  compared  with  vehicle
controls.
DISCUSSION
p53 plays an important role in normal eye development. In
p53−/− mice derived from the Jackson Laboratory colony, the
hyaloid vasculature persists and develops into a fibrovascular
retrolental plaque that leads to cataract formation in young
adult  mice  [22,23].  This  developmental  ocular  anomaly
occurs in p53-deficient C57BL/6 mice but not in the p53-
deficient  129/Sv  strain,  indicating  the  importance  of
background strains [23]. The p53-deficient mice used in the
present study have no such abnormalities.
p53 is a major regulator of cell death in response to
various stresses that involve DNA damage [24]. However,
both p53-dependent and p53-independent mechanisms may
exist in the retinal degeneration models depending on the type
and degree of stress to the retina [25,26]. MNU causes DNA
adduct  formation  in  photoreceptor  nuclei,  followed  by
increased  poly(ADP-ribose)  polymerase  activity.  It  leads
through inactivation of nuclear factor-κB and the activation
of Jun N-terminal kinase/activator protein. Then it causes
downregulation  of  Bcl-2,  upregulation  of  Bax,  and  the
activation of Caspase-3, -6, and -8 [5,20,27]. In the present
study,  retinal  degeneration  that  was  characterized  by  the
disappearance of the outer nuclear layer and the photoreceptor
layer in both the peripheral and central retina was detected in
p53−/− mice, p53+/− mice, and p53+/+ mice 7 days after a single
i.p. injection of 60 mg/kg MNU. Morphometric indices, such
as  the  retinal  photoreceptor  ratios  in  the  central  and  the
peripheral retina and the retinal damage ratio, revealed that
the degree of retinal lesions in MNU-treated p53−/− mice was
similar to that of MNU-treated p53+/− and p53+/+ mice. Our
present results indicate that MNU induces p53-independent
Figure 4. Retinal damage ratio in N-methyl-N-nitrosourea (MNU)-
treated p53−/−, p53+/−, and p53+/+ mice. The retinal damage ratio was
calculated as the percentage of length of retina composed of less than
four photoreceptor cells on the length of whole retina. Asterisk is
p<0.01 and compared with vehicle controls.
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2922retinal degeneration. The MNU-treated p53−/− mice revealed
a statistically significant weight loss compared to the other
groups.  Histopathologically,  a  severe  degree  of  atrophic
changes was detected in the lymph–hematopoietic system
(thymus, spleen, lymph node, bone marrow) in MNU-treated
p53−/− mice. The cause of the significant weight loss in MNU-
treated  p53−/−  mice  seems  to  be  due  to  systemic  toxicity
induced by MNU.
Calpains  (calcium-dependent  cysteine  proteases)  are
activated  by  increased  cellular  Ca2+  concentration.
Excitotoxic stimuli results in a massive Ca2+ influx into the
target  cells,  and  poly(ADP-ribose)  polymerase  activation
caused by DNA damage further dysregulates Ca2+, which
results in calpain activation, and is followed by cell death.
Total Ca2+ in the retina of MNU-treated rats is significantly
increased and calpain activity is dramatically increased 1 and
3 days after MNU and decreased at day 7 [28,29]. The role of
calpain family proteases in the p53-independent apoptosis
pathways after MNU exposure is unclear and needs further
investigation.
Light-induced  photoreceptor  cell  death  is  p53
independent. When p53−/− and p53+/+ mice were dark adapted
for 36 h and then exposed to more than 8,000 lux for 2 h, the
degree of photoreceptor cell damage was the same in both
genotypes  [30,31].  In  an  inherited  model  of  retinal
degeneration,  mice  carrying  the  rd  gene  develop
photoreceptor degeneration early in life. Although the retinal
development in rd mice is comparable to that in normal mice
at 8 days of age, the number of photoreceptor in rd mice is
reduced by 11 days of age and the photoreceptor cells are
completely missing or reduced to a single layer of cells by 20
days of age [32]. When the retinas of 10- to 20-day-old p53−/
− rd/rd  and  p53+/+ rd/rd  mice  were  compared,  the
photoreceptor cell loss was indistinguishable, suggesting that
photoreceptor  apoptosis  in  rd  mice  occurs  in  a  p53-
independent manner [33,34]. In mice carrying the rds gene,
photoreceptor cell loss starts at 2 weeks of age and progresses
slowly with complete loss occurring 1 year after birth [3]. A
comparison of p53−/− rds/rds mice and p53+/+ rds/rds mice
revealed that the retina develop similarly [35]. Although a
slight delay in photoreceptor apoptosis occurred between 16
and 26 days of age in p53−/− rds/rds mice, the amount of
photoreceptor  cell  loss  was  similar  at  35  days  of  age,
indicating that photoreceptor apoptosis in rds mice is p53
independent. Thus, inherited as well as excitotoxic stimuli
cause p53-independent apoptosis in photoreceptor cells.
p53 may regulate apoptosis differently in different types
of retinal cells. Retinal ganglion cell (RGC) death is induced
by  N-methyl-D-aspartate  (NMDA)  [36].  When  160  nM
NMDA was intravitreally injected into p53+/+, p53+/−, and
p53−/−  mice,  the  p53+/+  and  p53−/−  mice  exhibited  a
statistically equivalent amount of RGC loss at 4 days after the
treatment, while the p53+/− mice had significantly attenuated
cell loss. In p53+/+, p53+/−, and p53−/− mice, the cleavage of
poly(ADP-ribose),  which  is  a  substrate  for  caspases,  was
found  in  p53+/+  and  p53+/−  eyes  but  not  in  p53−/−  eyes.
Although the mechanism that protects p53+/− mice from RGC
death needs further study, the NMDA-induced RGC death
was p53 dependent; however, p53-independent pathways also
exist.
Radiation-induced apoptosis in retinal progenitor cells in
the inner nuclear layer is p53 dependent [37,38]. When 5-day-
old  p53+/+  and  p53−/−  mice  received  14  Gy  whole  body
irradiation [38], the p53+/+ retina contained activated p53 in
the retinal progenitor cells of the inner retina (but not in the
outer retina) 2 h after irradiation, and apoptotic cells appeared
in the inner nuclear layer 5 h after irradiation; however, retinal
cell death was completely abrogated in the p53−/− retina. In 3-
to 4-day-old p53+/+,p53+/−, and p53−/− mice, the p53−/− retina
was completely resistant to 14 Gy irradiation, while a p53 gene
dosage  effect  was  observed  after  2  Gy  irradiation;  p53−/−
retinas were completely protected, while p53+/− retinas were
partially  protected  [37].  Thus,  the  involvement  of  p53  in
radiation-induced  retinal  cell  death  seems  to  be  cell-type
specific and dose dependent.
In conclusion, after a single i.p. injection of 60 mg/kg
MNU,  retinal  degeneration  occurred  in  p53−/−  and  p53+/−
mice. The degree of retinal degeneration in these mice was
similar to that of MNU-treated p53+/+ mice. Therefore, p53
may  not  be  essential  for  MNU-induced  photoreceptor
degeneration in mice. Detailed investigations of p53 gene
function in human RP are needed for a better understanding
of the pathogenesis of RP.
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